Astrocytes are considered the third component of the synapse, responding to neurotransmitter release from synaptic terminals and releasing gliotransmitters-including glutamate-in a Ca 2+ -dependent manner to affect neuronal synaptic activity. Many studies reporting astrocyte-driven neuronal activity have evoked astrocyte Ca 2+ increases by application of endogenous ligands that directly activate neuronal receptors, making astrocyte contribution to neuronal effect(s) difficult to determine. We have made transgenic mice that express a Gqcoupled receptor only in astrocytes to evoke astrocyte Ca 2+ increases using an agonist that does not bind endogenous receptors in brain. By recording from CA1 pyramidal cells in acute hippocampal slices from these mice, we demonstrate that widespread Ca 2+ elevations in 80%-90% of stratum radiatum astrocytes do not increase neuronal Ca 2+ , produce neuronal slow inward currents, or affect excitatory synaptic activity. Our findings call into question the developing consensus that Ca 2+ -dependent glutamate release by astrocytes directly affects neuronal synaptic activity in situ.
SUMMARY
Astrocytes are considered the third component of the synapse, responding to neurotransmitter release from synaptic terminals and releasing gliotransmitters-including glutamate-in a Ca 2+ -dependent manner to affect neuronal synaptic activity. Many studies reporting astrocyte-driven neuronal activity have evoked astrocyte Ca 2+ increases by application of endogenous ligands that directly activate neuronal receptors, making astrocyte contribution to neuronal effect(s) difficult to determine. We have made transgenic mice that express a Gqcoupled receptor only in astrocytes to evoke astrocyte Ca 2+ increases using an agonist that does not bind endogenous receptors in brain. By recording from CA1 pyramidal cells in acute hippocampal slices from these mice, we demonstrate that widespread Ca 2+ elevations in 80%-90% of stratum radiatum astrocytes do not increase neuronal Ca 2+ , produce neuronal slow inward currents, or affect excitatory synaptic activity. Our findings call into question the developing consensus that Ca 2+ -dependent glutamate release by astrocytes directly affects neuronal synaptic activity in situ.
INTRODUCTION
There is a considerable body of evidence to suggest that astrocytes release transmitters-including glutamate-in a Ca 2+ -dependent manner to modulate activity at adjacent neuronal synapses. Glutamate release by astrocytes has been demonstrated in situ by changes in the synaptic activity of adjacent neurons (Angulo et al., 2004; Fellin et al., 2004; Fiacco and McCarthy, 2004; Pasti et al., 1997; Parri et al., 2001 elevations alone are sufficient to trigger release of glutamate by astrocytes. In a previous study by Pasti et al. (1997) , astrocyte Ca 2+ elevations triggered by the group I and II mGluR agonist trans-ACPD were correlated to neuronal Ca 2+ increases that were blocked by ionotropic glutamate receptor (iGluR) antagonists, suggesting that glutamate released by astrocytes was modulating neuronal activity. More recently, DHPG, a specific group I mGluR agonist, has been shown to increase NMDA receptor-mediated slow inward currents (SICs) in neurons in the presence of the Na + channel blocker TTX, an effect attributed to glutamate release by astrocytes (Angulo et al., 2004; Fellin et al., 2004) . However, DHPG also appears to have a strong direct effect on neurons, including elevating neuronal Ca 2+ , potentiating NMDA currents, and producing a long-term neuronal depolarization (Choe et al., 2006; Mannaioni et al., 2001) . It can therefore be difficult in studies employing endogenous agonists to dissect the potential contribution of astrocyte Ca 2+ elevations to changes in the activity of neurons versus effects produced by direct stimulation of neurons by the applied agonist. Uncaging IP 3 or Ca 2+ in single astrocytes provides specificity of the astrocyte stimulation. However, direct uncaging of second messengers is limited to a single astrocyte and cannot reproduce the complexity of signaling events that occur following stimulation of GPCRs.
We have developed transgenic mice that express a Gqcoupled metabotropic receptor only in astrocytes. This receptor, MrgA1, is normally expressed in dorsal root ganglion nociceptive sensory terminals in the spinal cord where it is activated by RF amide neuropeptides resulting in Ca 2+ release from internal stores (Dong et al., 2001 ). We of the MrgA1 receptor to astrocytes (Gossen and Bujard, 2002) . Thus, we have created a novel tool to study astrocyte-neuronal interactions in the brain, where we can selectively stimulate Ca 2+ mobilization in a large population of astrocytes while recording synaptic activity in adjacent neurons.
A recently discovered form of astrocyte-to-neuron communication in situ is NMDA receptor-mediated slow inward currents (SICs) in pyramidal neurons that are synchronized to astrocyte Ca 2+ increases. SICs have been observed spontaneously in the presence of TTX, suggesting that they are not driven by neuronal synaptic transmission, and they have also been evoked by DHPG administration, uncaging of Ca 2+ in single astrocytes, and mechanical stimulation of astrocytes (Angulo et al., 2004; Fellin et al., 2004; Parri et al., 2001; Perea and Araque, 2005) . In all cases, the neuronal SICs have been attributed to stimulation of astrocyte Ca 2+ mobilization and subsequent astrocytic release of glutamate. Here we show that synchronous, selective, widespread Ca 2+ elevations evoked in 80%-90% of hippocampal astrocytes by stimulation of astrocytic MrgA1 receptors do not affect basal miniature iGluR current activity, produce neuronal Ca 2+ elevations, or lead to the generation of neuronal SICs. SIC-like currents reliably occurred during perfusion with hypo-osmotic medium, in conditions in which astrocyte IP 3 receptor-mediated Ca 2+ mobilization and neuronal vesicular release of transmitter were completely blocked. These data indicate that agonist-induced astrocyte Ca 2+ increases alone are insufficient to produce SICs or modulate the activity of neuronal mEPSCs and that SIC-like currents occur in swelling-induced pathological conditions and are completely independent of astrocyte Ca 2+ elevations.
RESULTS

Gq-Coupled Receptor MrgA1 Is Expressed Specifically in Hippocampal Astrocytes
In order to selectively stimulate Ca 2+ increases in hippocampal astrocytes in situ by agonist administration, we created mice that express a Gq-coupled receptor in astrocytes that is not activated by ligands released in brain and whose ligand does not activate endogenous brain receptors. This receptor, called Mas-related gene A1 (MrgA1), is one of a family of GPCRs normally expressed in specific subsets of nociceptive sensory neurons (Dong et al., 2001) . The MrgA1 receptor was targeted to astrocytes using the inducible tet-off system ( Figure 1A ). In this system, the tetracycline transactivator (tTA) is targeted to astrocytes in transgenic mice using the human glial fibrillary acidic protein (hGFAP) promoter. These mice were crossed to mice in which the green fluorescent protein (GFP)-tagged MrgA1 receptor is transcribed off of the tet (tetO) minimal promoter. In the absence of doxycycline (dox), tTA binds to tetO and drives expression of the MrgA1-GFP construct ( Figure 1A ). This resulted in astro- Figure 1B , left panel, and Figure 1D ). McCarthy, 1999, 2000) . Neuronal labeling by NeuN did not colocalize with GFP fluorescence, indicating that neurons do not express MrgA1 ( Figure 1B , right panel). Similarly, NG2 staining of NG2 + glia did not overlap with GFP staining, indicating that NG2 + glia do not express the MrgA1 receptor ( Figure 1C ). It is important to note that occasional astrocytes not expressing MrgA1 appeared to be randomly scattered, not clustered together in small groups (Figure 1B, arrows) . This created a high confidence level that a given patch-clamped CA1 pyramidal neuron would ramify a large percentage of its dendritic arbors through a field of astrocytes expressing MrgA1 receptors (see below). synchronized Ca 2+ wave that radiated out from the astrocyte soma into proximal and then more distal compartments, as seen previously (Fiacco and McCarthy, 2004) ( Figure 3D ). Assuming functional MrgA1 receptor expression throughout the astrocyte and its processes, we predicted that Ca 2+ would elevate at the same time in all regions of interest (ROIs) over the cell following bath application of FLRFa, unlike the wave seen following uncaging of IP 3 . We were surprised, however, to find that Ca 2+ elevated first in a particular compartment(s), consistent with a Ca 2+ wave originating from a particular locus or loci in the cell ( Figure 3C ). Repeated activation of MrgA1Rs resulted in the repeated initiation of the Ca 2+ wave from the same intracellular locus (data not shown). The Ca
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wave triggered in response to FLRFa traveled at a velocity of 5.25 ± 0.8 mm/s (n = 4 astrocytes) from its point of initiation, significantly slower on average compared to the 12.42 ± 2.15 mm/s (n = 6 uncaging responses, 2 astrocytes) following uncaging IP 3 in the astrocyte soma (p = 0.0317, Student's t test; Figure 3 , see also Movie S1 in the Supplemental Data available online). In the four astrocytes studied, Ca 2+ always elevated first in a process following FLRFa administration. By comparing the positions of the particular processes among the different astrocytes, it was clear that the direction of the Ca 2+ wave could not be explained by a possible perfusion flow effect (drug diffusing across the cell from a particular direction). Such ''Ca 2+ wave initiation sites'' and ''wave amplification sites'' have been described previously in cultured preparations (Haak et al., 2001; Roth et al., 1995; Shuai and Jung, 2003; Yagodin et al., 1995) (B) In control mice expressing only tTA or the tetO MrgA1 construct, administration of peptide FLRFa did not produce a Ca 2+ increase in astrocytes bulk-loaded with Ca 2+ indicator. As a positive control for astrocyte Ca 2+ increases resulting from release from internal stores, an agonist cocktail consisting of histamine (10 mM), carbachol (10 mM), and 2Na-ATP (50 mM) was bath-applied. Scale bars, 10 mM.
from MrgA1 + mice. Previous studies reporting the existence of large, slow NMDA receptor-mediated neuronal inward currents (SICs) as a primary effect of astrocyte Ca 2+ stimulation (and subsequent glutamate release) (Angulo et al., 2004; Fellin et al., 2004; Parri et al., 2001; Perea and Araque, 2005) prompted us to mimic conditions used by the other laboratories in an effort to facilitate their occurrence. To this end, events were recorded in Mg 2+ -free ACSF in the presence of 1 mM TTX to prevent neuronal synaptic transmission, 10 mM D-serine to increase the probability of NMDAR activation by glutamate (D-serine has been shown to be a potent coagonist at the NMDA site in the hippocampus; Martina et al., 2003) , and 100 mM picrotoxin to block GABA A receptor-mediated synaptic inhibition ( Figure 4A Figure 4B ). Within each individual current recording, events were averaged before, during, and after the agonist-evoked astrocyte Ca 2+ increases. Averaged traces in Figure 4C are from the representative neuronal recording shown in Figure 4B . In a total of 13 recorded neurons from 13 slices from MrgA1 + mice, there was no significant effect of astrocyte Ca 2+ elevations on average mEPSC frequency, amplitude, or kinetics ( Figure 4D ). The recorded events had the appearance of synaptic events based on their smaller size and faster kinetics ( Figure 4D ), clearly different from the large amplitudes and extremely slow kinetics that have been reported for SICs ( 2004; Parri et al., 2001 ). The event distribution for amplitude and interevent intervals from all cells was plotted as cumulative probability before, during, and after MrgA1 receptor-mediated astrocyte Ca 2+ elevations ( Figure 4E ).
These distributions were analyzed using the KolmogorovSmirnov algorithm and were not statistically different (amplitude, p = 0.4273 before versus during, p = 0.3265 before versus after, p = 0.1210 during versus after; interevent interval, p = 0.0828 before versus during, p = 0.0719 before versus after, p = 0.07889 during versus after). In a similar set of experiments, application of AP5 blocked a tonic glutamate current and dramatically reduced synaptic ''noise'' due to activation of NMDAR conductances by ambient glutamate ( Figure S1 ), and yet widespread MrgA1R astrocyte Ca 2+ elevations had no effect on NMDAR activity. These findings strongly suggest that astrocyte Ca 2+ elevations are insufficient to produce neuronal SICs or significantly affect baseline miniature excitatory synaptic activity.
In control experiments, slices from MrgA1 À mice were used. Application of the MrgA1 receptor agonist peptide FLRFa did not produce astrocyte Ca 2+ elevations in MrgA1 À mice ( Figure 2B ), nor did we observe any effect on the neuronal current recording (n = 10 neurons, 10 slices; data not shown).
Stimulation of Astrocytic MrgA1Rs Does Not Result in Neuronal Ca 2+ Elevations
As an additional test for Ca 2+ -dependent glutamate release by astrocytes, we assayed for increases in neuronal Ca 2+ levels during stimulation of astrocytic MrgA1Rs.
It was previously reported that application of agonists to (Fellin et al., 2004; Pasti et al., 1997) . The Ca 2+ elevations previously reported were measured in cell bodies and, similar to reported SICs, synchronized among small groups of pyramidal neurons. In our experiments, pyramidal neurons in CA1 were patch-clamped with Alexa 568 to view their morphology and Fluo-4 to measure changes in Ca 2+ . In one set of experiments (n = 5 neurons, 5 slices), neurons were patch-clamped for 10 min and then, following pipette removal, given 15 min for dye equilibration and cell recovery prior to beginning Ca 2+ measurements. In a second set of experiments, neurons were maintained in currentclamp to record cell resting membrane potential during measurements of neuronal Ca 2+ (n = 4 neurons, 4 slices) ( Figure 5 ). Both sets of experiments were performed in Mg 2+ -free ACSF + 10 mM D-serine, 100 mM picrotoxin, and 10 mM of the AMPAR antagonist NBQX to provide ideal conditions for an astrocytic glutamatergic modulation of neuronal NMDARs. Calcium activity was recorded in secondary oblique dendrites and neuronal spines ( Figure 5A ), primary sites of glutamatergic input from Schaffer collateral terminals (Frick et al., 2003; Sobczyk et al., 2005) . In both sets of experiments, application of FLRFa to stimulate astrocytic MrgA1Rs failed to produce Ca 2+ elevations in neuronal dendrites ( Figure 5B ). As a positive control for neuronal Ca 2+ elevations, 15 mM DHPG was administered, which reliably triggered a longlasting depolarizing shift in membrane potential (6.02 ± 0.75 mV, n = 4 neurons), firing of neuronal action potentials, and Ca 2+ spiking. The Ca 2+ elevations appeared to be the result of back-propagating action potentials triggered by the direct long-lasting depolarizing effect of DHPG on neurons (Mannaioni et al., 2001; Rae and Irving, 2004) , because the synchronized action potentials and Ca 2+ elevations were blocked by TTX. We were unable to produce reliable neuronal Ca 2+ increases during DHPG application with TTX present, suggesting that the 15 mM concentration of DHPG used was too low to elicit Ca 2+ release from neuronal dendritic stores. Previous studies used between 30 and 100 mM DHPG to elevate neuronal Ca 2+ levels (Bianchi et al., 1999; Mannaioni et al., 2001; Rae and Irving, 2004) . A higher concentration of DHPG was not used because we wanted to maintain a similar concentration previously used by other groups to elicit neuronal Ca 2+ elevations and SICs that were attributed to glutamate release by astrocytes (Angulo et al., 2004; Fellin et al., 2004 in Single Astrocytes Produces Neuronal SICs Previous studies have shown that both bath application of 10-15 mM DHPG (Angulo et al., 2004; Fellin et al., 2004) and uncaging Ca 2+ in single astrocytes (Fellin et al., 2004 ) produce slow inward currents in neurons. We Figures 6A-6D ). Application of DHPG did not affect the NMDA mEPSCs recorded in this neuron ( Figures 6B  and 6C ). Interestingly, DHPG, but not FLRFa, produced an obvious effect on the neuronal current recording: a baseline shift in inward current of 17.5 ± 2.9 pA (n = 9 neurons), indicative of a long-term cellular depolarization as seen previously (Mannaioni et al., 2001; Rae and Irving, 2004 ) ( Figure 6B ). Because the effect of 15 mM DHPG on astrocyte Ca 2+ was negligible compared to 5 mM FLRFa ( Figure 6B ), the data suggest that DHPG-induced neuronal depolarization occurs independent of astrocyte Ca
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elevations and therefore is due to a direct action of DHPG on neuronal mGluRs. During the course of these experiments, IP 3 R2 knockout mice became available to us from the lab of Dr. Ju Chen at the University of California at San Diego (Li et al., 2005) . Because glial cells including astrocytes, oligodendrocytes, and NG2 + glia only express the type 2 IP 3 receptor while neurons also express IP 3 R1 and IP 3 R3 (Holtzclaw et al., 2002; Sharp et al., 1999) , IP 3 R2 knockout should eliminate astrocytic IP 3 receptor-dependent Ca 2+ increases while leaving intact neuronal IP 3 receptor signaling. In hippocampal slices from IP 3 R2 KO mice bulkloaded with Ca 2+ indicator, 0/69 (0%) of astrocytes from nine slices responded to a metabotropic receptor agonist cocktail consisting of histamine (10 mM), carbachol (10 mM), and DHPG (10 mM), while 44/51 (86%) of astrocytes from six slices from IP 3 R2 +/À mice responded with Ca 2+ increases. These data demonstrated that IP 3 receptor-sensitive Ca 2+ elevations in astrocytes are completely blocked in IP 3 R2 KO mice. In six neuronal recordings from six hippocampal slices from IP 3 R2 KO mice, DHPG produced a 14.7 ± 3.1 pA inward shift in baseline current recorded in CA1 pyramidal cells. This effect was not significantly different from the inward current recorded in nine neurons from MrgA1 + mice following DHPG application (17.5 ± 2.9 pA; p = 0.541, Student's t test). These results strongly suggest that DHPG-induced depolarization of CA1 pyramidal neurons is due to direct action of DHPG on neuronal group I mGluRs, not due to astrocyte Ca 2+ elevations and putative gliotransmitter release.
To determine whether DHPG could produce neuronal SICs in MrgA1 + transgenic mice, the NMDA event amplitudes and decay taus were analyzed from nine neuronal recordings in nine slices ( Figure 6D ). There was no effect of DHPG on the average amplitude and decay tau (decay tau baseline versus DHPG, p = 0.5310, Student's t test). Cumulative probability of amplitude and decay tau was also plotted in the two conditions and analyzed using the Kolmogorov-Smirnoff test ( Figure 6D , right panels).
There was no significant difference in these parameters recorded in DHPG versus baseline (amplitude, p = 0.3543; decay tau, p = 0.7747). Because SICs on average are much larger and slower compared to synaptically mediated events, the data strongly suggest that SICs do not occur during DHPG application. We also tested for astrocyte-mediated neuronal SICs by uncaging Ca 2+ in astrocytes in wild-type C57BL/6J mouse hippocampal slices (Figures 6E-6H ). Caged Ca 2+ was bulk-loaded into astrocytes together with the Ca 2+ indicator dye Fluo-4. This method has been used successfully by other groups to show neuronal SICs correlated to the evoked astrocyte Ca 2+ elevations (Fellin et al., 2004) .
Uncaging Ca 2+ in a single astrocyte ( Figure 6E , box 10) did not affect the isolated NMDA mEPSCs recorded in this neuron ( Figures 6F and 6G ). Average amplitude and decay tau were not statistically different during evoked astrocyte Ca 2+ elevations versus baseline (decay tau, p = 0.3508, n = 3 neuron-astrocyte pairs; Figure 6H ). Due to variability in decay tau measurements in small sample (B) Bath application of DHPG (15 mM) produced a long-lasting inward current, despite a minimal effect on astrocyte Ca 2+ (lower-numbered traces that (H) Amplitude, decay tau, and area of NMDA events averaged over three neuron-astrocyte pairs were not statistically different (decay tau p = 0.3508, Student's t test). Error bars indicate SEM. Cumulative probability of amplitude and area were plotted to show the complete distribution of these parameters (right panels). Scale bars, 10 mM.
sizes, we also measured average area (pA$ms), which was the same in baseline versus during evoked astrocyte Ca 2+ increases ( Figure 6H ). Cumulative probability of amplitude and area was not statistically different in baseline versus evoked astrocyte Ca 2+ increases (amplitude, p = 0.9759; area, p = 0.7841, Kolmogorov-Smirnov test). These data provide further evidence that evoked astrocyte Ca 2+ increases do not lead to the production of large slow inward currents in neurons. Figure S3 ), (2) an increase in inward current and synaptic noise due to elevated ambient glutamate concentration acting on NMDA receptors, and (3) a tonic activation of NMDARs by basal levels of ambient glutamate (Figure 7 ). Similar to the data shown in Figure S3 , stimulation of astrocyte Ca 2+ by activation of endogenous Et receptors did not affect the individual miniature excitatory synaptic currents (Figures 7A and 7B) . Application of the astrocyte GLT-1 glutamate transporter inhibitor dihydrokainate (DHK, 100 mM) produced an inward shift in baseline current and an increase in synaptic noise suggesting an enhanced tonic activation of iGluRs due to elevated ambient glutamate concentration ( Figures 7A and 7C ). This was confirmed by blocking the effect of DHK by application of the NMDA and AMPAR antagonists DL-AP5 and NBQX (Figures 7A and 7C ). In addition to blocking the DHK effect, the iGluR antagonists reduced the amount of baseline current prior to DHK application, indicating that iGluRs sense basal concentrations of ambient glutamate. We found similar results on the holding current and level of noise using the NMDAR antagonist DL-AP5 alone, suggesting that NMDA receptors are the predominant iGluR subtype that is activated by ambient glutamate (see also Figure S1 ). In addition to producing no effect on the iGluR mEPSCs, stimulation of endogenous astrocytic EtRs also did not affect the level of synaptic noise, which was comparable to the level observed in the presence of the iGluR antagonists and much less than that observed in the presence of DHK ( Figure 7C ). The data from these experiments strongly suggest that astrocyte Ca 2+ elevations do not result in a glutamatergic modulation of neuronal iGluR synaptic activity. In our next set of experiments, we sought to determine whether SICs could be evoked in nonphysiological conditions. Astrocytes have been shown to release glutamate in a nonvesicular, Ca 2+ -independent manner in conditions that lead to cell swelling, such as ischemia, hyponatraemia, and brain trauma (Abdullaev et al., 2006; Fellin et al., 2006; Kimelberg, 2004; Liu et al., 2006b) . Recently, Kozlov et al. (2006) observed that astrocyte-driven neuronal SICs recorded in rat olfactory bulb were enhanced 1-6 ). There were no changes observed in the level of spontaneous iGluR synaptic activity or in the level of synaptic noise during the astrocyte Ca 2+ elevations compared to baseline neuronal recording. However, application of the astrocytic GLT-1 glutamate transporter inhibitor DHK (100 mM) produced both an increase in inward current as well as an increase in the level of synaptic noise. Application of DL-AP5 and NBQX blocked the increase in iGluR activation by DHK as well as a tonic inward current that was present prior to DHK application. (B) Portions of the neuronal recording during baseline (1) versus during astrocyte Et-evoked Ca 2+ elevations (2) are shown in an expanded timescale for easier comparison. There was no effect of the astrocyte Ca 2+ elevations on the neuronal recording.
(C) Comparison of the level of synaptic noise during astrocyte Ca 2+ elevations (upper trace), during DHK administration (middle trace), and in the presence of DL-AP5 + NBQX (lower trace) shown in expanded timescale reveals no effect of astrocyte Ca 2+ elevations on the level of iGluR-mediated synaptic noise. These data were replicated in five recordings from five hippocampal slices.
significantly in hypo-osmotic medium, suggesting a possible involvement of volume-regulated anion channels (VRACs) in a Ca 2+ -independent form of glutamate release. To test the possibility that SIC-like events occur preferentially in hypo-osmotic conditions, we recorded neuronal NMDA mEPSCs from MrgA1 + mice in Mg 2+ -free ACSF (+ 10 mM D-serine, 100 mM picrotoxin, 1 mM TTX, 10 mM NBQX) before and during switch to À25 mM NaCl solution. Switch to hypo-osmotic ACSF reliably evoked SIC-like events in CA1 pyramidal cells ( Figure 8A ). The SIC-like currents were frequent during the initial application of the hypo-osmotic solution but continued to occur at low frequency until switch back to normo-osmotic ACSF. These events were of large amplitude, on average (107.9 ± 25.5 pA), with slow kinetics (10%-90% rise 55 ± 13.8 ms; decay tau 179.8 ± 45.8 ms, n = 20 events from 3 neurons, 3 slices). The SICs were difficult to detect in hypo-osmotic solution containing 1.3 mM Mg 2+ (n = 4 neurons) and blocked by 50 mM DL-AP5 (n = 6 neurons), indicating that they are mediated by NMDA receptors ( Figure 8B ).
We then performed experiments to determine whether (1) the SIC-like events depend upon vesicular release of transmitter from neurons and (2) whether the SIC-like events require Ca 2+ mobilization from astrocyte internal stores. To this end, five slices from IP 3 R2 KO mice were incubated for a minimum of 1 hr in 4 mM bafilomycin A1, an inhibitor of the vacuolar ATPase responsible for glutamate loading into synaptic vesicles. As discussed previously, astrocytes from IP 3 R2 KO mouse slices are completely incapable of mobilizing Ca 2+ from IP 3 receptor-dependent internal stores (see above). Neuronal recordings from bafilomycin-treated IP 3 R2 KO slices (+1 mM TTX) were nearly completely devoid of NMDA receptor-mediated synaptic activity compared to slices not incubated in bafilomycin ( Figure 8C ), indicating a thorough block of neuronal vesicular release of glutamate. However, SIC-like events continued to occur under these conditions in hypo-osmotic ACSF (average amplitude, 65.5 ± 15.3 pA; average 10%-90% rise time, 42.2 ± 7.3 ms; average decay tau 122.0 ± 26.7 ms; n = 45 events from 5 neurons, Figure 8D ). Collectively, these data suggest that (1) SIC-like currents occur in pathological conditions and are biologically distinct from neuronal mEPSCs, (2) they occur independent of vesicular release of transmitter from neurons, and (3) they occur independent of IP 3 receptor-dependent astrocyte Ca 2+ elevations. release of transmitter or astrocyte IP 3 receptor-mediated Ca 2+ elevations.
DISCUSSION
We have created a novel tool to study astrocyteneuronal signaling. By expressing a Gq-coupled receptor (MrgA1) only in astrocytes that is activated by a ligand not endogenously expressed in brain, we have directly assessed the contribution of astrocyte Ca 2+ signaling on excitatory neuronal receptor activity. Activation of the MrgA1 receptors in astrocytes by the RF amide peptide FLRFa produced robust, repeatable, long-lasting Ca 2+ elevations in a very high percentage (80%-90%) of stratum radiatum astrocytes. We were surprised to discover that MrgA1 receptor-evoked astrocyte Ca 2+ elevations did not affect excitatory synaptic activity of CA1 pyramidal neurons, given the large number of previous studies indicating that astrocyte Ca 2+ increases alone are necessary and sufficient for glutamate release by astrocytes (Araque et al., 1998a (Araque et al., , 1998b Haydon, 2001; Parpura et al., 1994 These data indicate that expression and activation of astrocytic MrgA1Rs does not aberrantly affect endogenous signaling cascades activated by Gq GPCR stimulation. Uncaging IP 3 in MrgA1 + astrocytes resulted in a significant increase in the frequency of AMPA sEPSCs, as we observed previously in slices from wild-type hippocampus (Fiacco and McCarthy, 2004) , indicating that expression of the MrgA1 receptors in astrocytes does not interfere with the ability of astrocytes to modulate neuronal activity (Figure S2) . Furthermore, in experiments demonstrating lack of effect of astrocyte Ca 2+ elevations on neuronal activity by activation of (1) astrocytic MrgA1Rs in transgenic mice ( Figure S1 ) and (2) endogenous endothelin receptors in wild-type mice (Figure 7) , we observed that NMDARs are actively sensing ambient glutamate and changes in ambient glutamate concentration. The data overall suggest that astrocytes do not release glutamate following activation of endogenous Gq GPCRs in wild-type mice or MrgA1 Gq GPCRs in the MrgA1 + transgenic mice.
As an additional test to determine whether stimulation of astrocytic MrgA1Rs affects neuronal synaptic activity, we also recorded neuronal Ca 2+ in dendrites and spines during application of the MrgA1R agonist FLRFa. It had been previously demonstrated in situ, first by Pasti et al. (1997) and more recently by Fellin et al. (2004) , that evoked astrocyte Ca 2+ elevations produced large somatic Ca 2+ elevations in groups of adjacent pyramidal neurons bulk-loaded with Ca 2+ indicator. In both studies, astrocytes were stimulated using agonists to endogenous mGlu receptors: tACPD by Pasti et al. (1997) and DHPG by Fellin et al. (2004) . In the present study, we observed no changes in neuronal Ca 2+ in secondary dendrites and associated dendritic spines during selective stimulation of astrocytic MrgA1 Gq GPCRs. Recording Ca 2+ in secondary dendrites of CA1 pyramidal neurons should be a very sensitive assay for neuronal Ca 2+ elevations triggered by activation of iGluRs compared to measurements made in the cell body as was done previously. These data suggest that Ca 2+ -dependent release of glutamate by astrocytes does not result in Ca 2+ influx via activation of neuronal iGluRs and corroborate our findings showing no effect on neuronal iGluR synaptic currents. Because our measurements were done primarily in dendritic compartments and not selectively in dendritic spines, we cannot rule out the possibility that astrocytes are influencing synaptic Ca 2+ activity on a scale that was beyond the level of detection used in our study. Such a level of detection should not be necessary, however, to measure the type of Ca 2+ increases reported previously in groups of neurons attributed to synchronization of neuronal SICs (Fellin et al., 2004) . Due to the specificity of astrocytic Ca 2+ activation in the MrgA1 + mice, our results also raise the possibility that the nonselective mGluR agonists used in the previous studies were evoking neuronal Ca 2+ increases that were not astrocyte mediated. DHPG is known to have a number of direct actions on CA1 pyramidal neurons, including elevating Ca 2+ , depolarization, and increased cell firing and potentiation of NMDA receptor currents (Heidinger et al., 2002; Liu et al., 2006a; Mannaioni et al., 2001; Pisani et al., 2001; Rae and Irving, 2004) . We have demonstrated using a combination of MrgA1 + transgenic mice together with IP 3 R2 knockout mice that the depolarizing effect of DHPG occurs completely independent of astrocyte Ca 2+ elevations, raising the possibility that other effects of DHPG previously reported in neurons-including Ca 2+ elevations and neuronal SICs-are produced by directly activating mGluRs on neurons or indirectly by activating mGluRs on other (nonastrocytic) cell types. Finally, it is possible that the synchronized neuronal Ca 2+ elevations reported previously in neonatal rat slices were a product of early development and therefore difficult to reproduce in more mature tissue. In support of this, Parri et al. (2001) indicated that the neuronal Ca 2+ elevations and SICs they observed in neonatal VB thalamus of the rat that were synchronized to spontaneous astrocyte Ca 2+ elevations showed a clear developmental profile.
We provide data showing that changes in osmolarity are sufficient to produce SICs. Recently, Kozlov et al. (2006) reported that SICs and SOCs (slow outward currents) in neurons of the rat olfactory bulb were significantly enhanced in frequency in hypo-osmotic conditions and were almost completely inhibited in hyperosmotic conditions. The authors concluded that the sensitivity of SICs and SOCs to the osmolarity of the extracellular solution was a strong argument in favor of an anion channel-mediated mechanism of glutamate release, which is a Ca 2+ -independent form of transmitter release. The findings of Kozlov et al. led us to try the same approach to detect SICs in our acute hippocampal slices. We also readily demonstrated the occurrence of NMDA receptor-mediated, SIC-like events in CA1 pyramidal neurons during perfusion with hypo-osmotic ACSF. These SICs were not inhibited during block of neuronal vesicular release by TTX and bafilomycin in slices from IP 3 R2 knockout mice, in which astrocytic IP 3 receptor-driven Ca 2+ elevations were completely blocked. These results suggest that SIC-like events occur during cell swelling, are not driven by vesicular release of transmitter from neurons, and are not dependent on astrocyte Ca 2+ elevations. Because both astrocytes and neurons express anion channels (Abdullaev et al., 2006) , further work will be necessary to determine the source of the glutamate driving the swelling-induced, SIC-like events. Finally, the lack of effect of astrocyte Ca 2+ elevations in MrgA1 + transgenic and wild-type mice on the amplitude, frequency, or kinetics of iGluR mEPSCs may appear somewhat puzzling, given our previous work demonstrating increased frequency of AMPA sEPSCs following astrocyte Ca 2+ elevations evoked by uncaging IP 3 in single astrocytes (Fiacco and McCarthy, 2004) . However, the discrepancy in these findings might be explained by a number of differences in experimental conditions. The foremost among these is that Ca 2+ -dependent glutamate release by astrocytes may be strongly influenced by the specific technique(s) used to stimulate the astrocytes. This possibility is supported by our ability to measure an increased frequency of AMPA sEPSCs following uncaging of IP 3 in the MrgA1 + mice ( Figure S2 ). Uncaging IP 3 produced Ca 2+ responses that propagated through the astrocyte much more rapidly compared to the MrgA1-induced responses ( Figures 3A-3D , see also Movie S1 
EXPERIMENTAL PROCEDURES
Generation of Gq-Coupled Receptors Targeted to Astrocytes GFAP-tTA mice have been previously described (Lin et al., 2004; Pascual et al., 2005) . For tetO-MrgA1 constructs, the tetO-minimal CMV promoter was removed from pUHD10-3 (kindly provided by Dr. Hermann Bujard, ZMBH, University of Heidelberg) and placed upstream of heterologous intron in pTg-1 (kindly provided by Dr. Randy Thresher, University of North Carolina at Chapel Hill). MrgA1-GFP fusion sequence (kindly provided by Dr. Xinzhong Dong, Howard Hughes Medical Institute, California Institute of Technology) was cloned into pTg-1, downstream of intron. The pTg-1 provides SV40 poly A signal for cDNA cassettes. For tetO-lacZ, lacZ sequence from pCH110 (Clontech) was cloned downstream of tetO promoter in pTg-1. For tetO-MrgA1 mice, the two tetO-responsive constructs were digested away from prokaryotic sequence and coinjected into C57 3 C3H hybrid oocytes by the Animal Models Core Facility at UNC-CH. Founder mice were identified by PCR, crossed to GFAP-tTA mice, and screened for transgene expression. All mice were kept in the animal facilities at the University of North Carolina, Chapel Hill in accordance with Institutional Animal Care and Use Committee guidelines.
Immunofluorescence
Mice (P15 or adult [>P60]) were deeply anesthetized with urethane and perfused with ice-cold PBS followed by 4% paraformaldehyde (PF)/ 0.1 M NaPO 4 , pH 7.4. Brains were removed and postfixed for 2 hr at 4 C in 4% PF/0.1 M NaPO 4 , pH 7.4, before cryoprotecting in 30% sucrose and subsequent freezing in OCT. Staining was performed as previously described (Casper and McCarthy, 2006) . Primary antibodies were applied at the following dilutions: rabbit anti-GFP (1:500, Chemicon), mouse anti-GFAP (1:1000, Sigma), mouse antiNeuN (1:500, Chemicon), rabbit anti-NG2 (1:1000, Chemicon), mouse anti-GFP (1:500, Sigma). Secondary antibodies, Alexa 488 or 594 conjugated goat anti-mouse and anti-rabbit, were from Molecular Probes and used at 5 mg/ml.
Preparation of Hippocampal Slices and Bulk-Loading
Parasagittal hippocampal slices (300 mm thick) were prepared from 10-to 17-day-old C57BL/6J (Jackson Laboratory, Bar Harbor, ME), hGFAP-tTA:: tetO MrgA1 (MrgA1 construct obtained from Dong et al., 2001) , or IP 3 R2 KO mice (Li et al., 2005) , using a Leica VT1000s Vibratome (Bannockburn, IL (Porter and McCarthy, 1996) and mice (Nett et al., 2002) . Following the incubation period at physiological temperature, slices were given 15 min to cool to room temperature. Once slices equilibrated to room temperature, they were transferred to a recording chamber and continuously superfused with oxygenated, room temperature ACSF. -free ACSF + 100 mM picrotoxin, 10 mM D-serine, and 1 mM TTX. In some experiments where indicated, the Mg 2+ -free external solution was the same as described above with the addition of 10 mM NBQX to isolate neuronal slow inward currents (SICs). Upon attaining the whole-cell configuration, the cell membrane potential, input resistance, and access resistance were recorded, and the external solution was then switched to the Mg 2+ -free solution described above. Slices were bathed in the Mg 2+ -free solution for 8 min prior to the initiation of the neuronal gap-free current recording. We have observed that it takes approximately 5-8 min in Mg 2+ -free solution for spontaneous NMDA currents to appear. When isolated by including 10 mM NBQX to block AMPA currents, NMDA mEPSCs have significantly slower kinetics and tend to be noisier compared to AMPA currents. Access resistances were monitored in order to ensure that the access did not change more than 20%. During neuronal recordings, drugs were added to the perfusion solution using an electronic valve controller (Warner Instrument, Hamden CT). Drugs used to initiate astrocyte Ca 2+ elevations, including the MrgA1 receptor agonist peptide FLRFa, were applied for 70-90 s depending upon the delay to the initiation of the astrocyte Ca 2+ response. In control experiments performed using littermates expressing either tTA or MrgA1 (but not both together, which would indicate expression of the MrgA1 receptor, see above), FLRFa was added for a full 2 min in order to ensure lack of astrocyte Ca 2+ responses.
Patch-Clamp of Astrocytes
Because there is a delay to the onset of the Ca 2+ increase relative to the switch in perfusion solution (wash-in time), we used specialized software to time synchronize astrocyte Ca 2+ increases to the neuronal recording (Physiolink; Olympus, Melville, NY). This allowed us to precisely analyze any changes in neuronal currents relative to changes in astrocyte Ca
2+
.
Confocal Imaging and IP 3 and Ca 2+ Uncaging
Dye-filled neurons and astrocytes were visualized using an Olympus Fluoview 300 argon/krypton confocal microscope. Changes in fluorescence intensity over time were recorded in astrocytes and neurons by placing analysis boxes (ROIs) over individual cellular compartments, using Olympus Fluoview v.5 software. Increases in average fluorescence intensity over baseline fluorescence (DF/F 0 ) within the ROI indicated increases in Ca 2+ concentration (Takahashi et al., 1999) . Caged IP 3 was uncaged by a short (5-10 pulses) train of 10-15 ms, 30 mW, 2.5 mM diameter pulses from a Coherent UV laser (Santa Clara, CA). Caged Ca 2+ was uncaged using 20-30 100 ms, 100 mW pulses.
Analysis of Synaptic AMPA/NMDA Currents Neuronal currents were analyzed before, during, and after astrocyte Ca 2+ increases using PCLAMP 9.2 software (Axon Instruments). A template intrinsic to each recording was created by averaging five individual mEPSCs together and used to detect individual events. Currents were not curve-fitted, and event statistics were taken for individual currents and then averaged, rather than taking the parameters from the averaged trace. Only events erroneously counted twice by the analysis software were rejected; otherwise, every event selected by the template was included in subsequent analyses. Amplitude, frequency, 10%-90% rise time, and decay taus were analyzed. Error bars in all graphs presented are SEM. Student's t test was used to test for statistical significance of individual current parameters between events before versus events during or after astrocyte Ca 2+ elevations. Due to the short durations characteristic of astrocyte Ca 2+ elevations, sample size of mEPSCs in individual pyramidal neurons was too small to run cumulative probability to compare events occurring during astrocyte Ca 2+ elevations to events occurring before or after. Therefore, data from the total number of cells were pooled prior to plotting cumulative probability, and therefore these data represent the entire population of cells rather than an individual ''representative'' cell. The KolmogorovSmirnov test was used to compare event distributions presented as cumulative probability. Degree of significance is denoted by an asterisk (*) for p < 0.05 and a double asterisk (**) for p < 0.01.
Visualization and Analysis of SIC-like Currents SIC-like events were reliably evoked by switch to hypo-osmotic solution prepared by omitting 25 mM NaCl from the Mg 2+ -free experimental ACSF (Mg 2+ -free ACSF + 100 mM picrotoxin, 10 mM D-serine, 1 mM TTX, and 10 mM NBQX). Often only a small number of SIC-like currents were observed in hypo-osmotic conditions (n = 7.7 events on average). Because of this, a template style of event detection was not ideal, as many of the same events used to create the template would be the ones analyzed in the recording. Therefore, these events were detected and measured using a threshold-based search strategy using PCLAMP 9.2 software. Threshold was set at the minimum level necessary to detect events over noise (8-10 pA from center of baseline). Events were not curve-fitted, and decay taus were calculated from 10% of peak amplitude. Events were analyzed during the first 2 min of perfusion with hypo-osmotic ACSF, when SIC-like events were most frequent.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/54/4/611/DC1/.
